For instance, Ki‐67 is a widely endorsed marker for a range of cancers Tumeh et al. (2014), but an issue has been raised concerning the reproducibility of IHC for Ki‐67 and the implications of variability in clinical decision-making (Curigliano et al., 2017). Here, MKI67 is linked to cancer.